Headache and pleocytosis in CSF associated with COVID-19: case report.
Felipe Araújo Andrade de OliveiraDanylo César Correia PalmeiraPedro Augusto Sampaio Rocha-FilhoPublished in: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology (2020)
In December 2019, a new coronavirus infection was identified in China. Although the clinical presentation of COVID-19 is predominantly respiratory, more than 35%% of patients have neurological symptoms. We report an elderly female with asthenia, dry cough, anosmia, ageusia, fever, nausea, and a severe and persistent headache. She had confirmed COVID-19 using the nasal swab RT-PCR technique. Her cranial tomography was normal. The CSF analysis demonstrated a cell count of 21 cells/mm3 (80% lymphocytes and 20% monocytes), 34 mg/dl protein, and 79 mg/dl glucose. She improved after 4 days. Our report draws attention to the meningeal involvement of SARS-Cov-2.
Keyphrases
- sars cov
- coronavirus disease
- respiratory syndrome coronavirus
- case report
- peripheral blood
- end stage renal disease
- induced apoptosis
- ejection fraction
- newly diagnosed
- chronic kidney disease
- single cell
- cell cycle arrest
- type diabetes
- prognostic factors
- cell therapy
- cell death
- sleep quality
- protein protein
- depressive symptoms
- adipose tissue
- insulin resistance
- blood glucose
- amino acid
- blood pressure
- brain injury
- binding protein
- african american